-
1
Comparative the efficacy and safety of Gosuranemab, Semorinemab, Tilavonemab, and Zagotenemab in patients with Alzheimer’s disease: a systematic review and network meta-analysis of...
Published 2025-01-01Subjects: “…anti-tau protein monoclonal antibodies…”
Get full text
Article